The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC Sept 2021 | Reflecting on WCLC 2021
Christopher Manley, MD, Fox Chase Cancer Center, Philadelphia, PA, discusses his highlights from the World Conference on Lung Cancer (WCLC) 2021. Dr Manley discusses the benefit of attending WCLC alongside colleagues with a diverse range of experience and praises the opportunity to gain new insights into the future of early- and late-stage lung cancer treatment. This interview took place at the WCLC 2021.
Disclosures
Dr Manley serves as a consultant for Johnson and Johnson and Auris Health. He has received research grant funding from Mauna Kea and Johnson and Johnson.
